Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Westerink

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Diabetes Care|June 4, 2015
Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different LocationsManon C Stam-Slob, Yolanda van der Graaf, Gert Jan de Borst, et al.
Obesity Research & Clinical Practice|December 4, 2022
Visceral adipose tissue quantity and dysfunction and the occurrence of major bleeding in patients with established cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Ynte M Ruigrok, et al.
European Journal of Internal Medicine|April 7, 2022
Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetesMarieke de Vries, Fatima El-Morabit, Karel J van Erpecum, et al.
Journal of Hypertension|October 1, 2019
Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitusJoris Holtrop, Wilko Spiering, Hendrik M Nathoe, et al.
Neurobiology of Aging|January 26, 2015
Hemoglobin, hematocrit, and changes in cerebral blood flow: the Second Manifestations of ARTerial disease-Magnetic Resonance studyPieternella H van der Veen, Majon Muller, Koen L Vincken, et al.
Cardiovascular Diabetology|July 20, 2016
The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular diseaseSophie H Bots, Yolanda van der Graaf, Hendrik M W Nathoe, et al.
Plos One|April 7, 2022
Chronic kidney disease and atrial fibrillation: A dangerous combinationGurbey Ocak, Meriem Khairoun, Othman Khairoun, et al.
Heart (British Cardiac Society)|March 15, 2020
Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular diseaseSteven H J Hageman, Gert Jan de Borst, Johannes A N Dorresteijn, et al.
BMC Health Services Research|September 1, 2022
The readiness of public primary health care (PUSKESMAS) for cardiovascular services in Makasar city, IndonesiaDian Sidik Arsyad, Esliana Fitrida Hamsyah, Nurul Qalby, et al.
BMC Endocrine Disorders|May 1, 2020
Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertensionMonique E A M van Kleef, Frank L J Visseren, Jan Westerink, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Diabetes Care|June 4, 2015
Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different LocationsManon C Stam-Slob, Yolanda van der Graaf, Gert Jan de Borst, et al.
Obesity Research & Clinical Practice|December 4, 2022
Visceral adipose tissue quantity and dysfunction and the occurrence of major bleeding in patients with established cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Ynte M Ruigrok, et al.
European Journal of Internal Medicine|April 7, 2022
Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetesMarieke de Vries, Fatima El-Morabit, Karel J van Erpecum, et al.
Journal of Hypertension|October 1, 2019
Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitusJoris Holtrop, Wilko Spiering, Hendrik M Nathoe, et al.
Neurobiology of Aging|January 26, 2015
Hemoglobin, hematocrit, and changes in cerebral blood flow: the Second Manifestations of ARTerial disease-Magnetic Resonance studyPieternella H van der Veen, Majon Muller, Koen L Vincken, et al.
Cardiovascular Diabetology|July 20, 2016
The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular diseaseSophie H Bots, Yolanda van der Graaf, Hendrik M W Nathoe, et al.
Plos One|April 7, 2022
Chronic kidney disease and atrial fibrillation: A dangerous combinationGurbey Ocak, Meriem Khairoun, Othman Khairoun, et al.
Heart (British Cardiac Society)|March 15, 2020
Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular diseaseSteven H J Hageman, Gert Jan de Borst, Johannes A N Dorresteijn, et al.
BMC Health Services Research|September 1, 2022
The readiness of public primary health care (PUSKESMAS) for cardiovascular services in Makasar city, IndonesiaDian Sidik Arsyad, Esliana Fitrida Hamsyah, Nurul Qalby, et al.
BMC Endocrine Disorders|May 1, 2020
Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertensionMonique E A M van Kleef, Frank L J Visseren, Jan Westerink, et al.
Pageof 12